PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is a significant public health challenge afflicting approximately 1 billion individuals both in the Western world and in the East world. While liver biopsy is considered as gold standard in the diagnosis and staging of liver fibrosis, noninvasive imaging tech...
Saved in:
| Main Authors: | Tuo Shao PhD, Lee Josephson PhD, Steven H. Liang PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-09-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.1177/1536012119871455 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO
by: Vidya Narayanaswami PhD, et al.
Published: (2018-09-01) -
Efficacy of Adding Sitagliptin to Ongoing Metformin on Metabolic Profile, Triglyceride-Glucose Index, Vitamin D3, and Liver Tests in Patients Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial
by: Habib Yaribeygi, PhD, et al.
Published: (2024-01-01) -
Preclinical PET Neuroimaging of [C]Bexarotene
by: Benjamin H. Rotstein PhD, et al.
Published: (2016-08-01) -
Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism
by: Nana L. Christensen MLS, et al.
Published: (2017-10-01) -
Quantification of Multi-Organ
11β-Hydroxysteroid Dehydrogenase
Type 1 Enzyme Levels in a Zucker
Fatty Rat Model: A PET Imaging Study
by: Jason Bini PhD, et al.
Published: (2024-12-01)